146 related articles for article (PubMed ID: 9413197)
21. Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier.
Nagamitsu A; Konno T; Oda T; Tabaru K; Ishimaru Y; Kitamura N
Eur J Cancer; 1998 Oct; 34(11):1764-9. PubMed ID: 9893666
[TBL] [Abstract][Full Text] [Related]
22. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
23. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
24. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
25. Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol.
Konno T
Eur J Cancer; 1992; 28(2-3):403-9. PubMed ID: 1317198
[TBL] [Abstract][Full Text] [Related]
26. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
27. [Experimental studies on the dynamics of anticancer agents in transcatheter arterial chemo-embolization. Magnetic resonance imaging using emulsions containing lipiodol and Gd-DTPA].
Ishio M
Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):285-95. PubMed ID: 1652593
[TBL] [Abstract][Full Text] [Related]
28. [Plasma platinum concentration and anti-tumor effects after intra-arterial infusion of lipiodol-CDDP suspension evaluation with VX 2 rabbit liver cancer model and 7.0 Tesla MRI system].
Sonoda A; Nitta N; Ohta S; Itoh R; Takahashi M; Murata K; Morikawa S; Inubushi T; Miyagawa Y; Takamori M; Oonaka Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):951-7. PubMed ID: 16835486
[TBL] [Abstract][Full Text] [Related]
29. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
[TBL] [Abstract][Full Text] [Related]
30. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
31. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
32. [Clinical or experimental use of an anticancer drug-oil suspension and its characteristics].
Kaneko H; Yamakawa T; Yamanaka Y; Sekizawa Y; Togo S; Nishiyama K; Tsuchiya S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2363-9. PubMed ID: 3015042
[TBL] [Abstract][Full Text] [Related]
33. Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.
Iwai K; Maeda H; Konno T; Matsumura Y; Yamashita R; Yamasaki K; Hirayama S; Miyauchi Y
Anticancer Res; 1987; 7(3 Pt B):321-7. PubMed ID: 2820293
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of intraarterial infusion of tumor necrosis factor/lipiodol emulsion on hepatic tumor in rabbits.
Watanabe D; Ueo H; Inoue H; Matsuoka H; Honda M; Shinomiya Y; Takamatsu T; Akiyoshi T
Oncology; 1995; 52(1):76-81. PubMed ID: 7800348
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H
Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716
[TBL] [Abstract][Full Text] [Related]
36. [Effect of percutaneous intratumoral injection of lipiodol emulsion of chemotherapie agents on implanted VX2 tumor in rabbits].
Song JW; Li YH; Chen Y; Yang Y; Liu XH; Ning JJ; Yang J; Shi XX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2526-9. PubMed ID: 21097424
[TBL] [Abstract][Full Text] [Related]
37. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
[TBL] [Abstract][Full Text] [Related]
38. Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits.
Furuta T; Kanematsu T; Kakizoe S; Sugimachi K
J Surg Oncol; 1988 Dec; 39(4):229-34. PubMed ID: 2848154
[TBL] [Abstract][Full Text] [Related]
39. Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.
Jourdan JL; Akhter J; Bowrey P; Pourgholami M; Morris DL
Anticancer Res; 2000; 20(4):2739-44. PubMed ID: 10953352
[TBL] [Abstract][Full Text] [Related]
40. [Effect of intra-arterially injected cisplatinum and lipiodol on the rat liver].
Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2787-92. PubMed ID: 2843134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
